Oncology Informatics Market
Report ID: SQMIG20I2788
Report ID: SQMIG20I2788
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG20I2788 |
Region:
Global |
Published Date: April, 2026
Pages:
157
|Tables:
118
|Figures:
77
Global Oncology Informatics Market size was valued at USD 4.42 Billion in 2024 and is poised to grow from USD 4.99 Billion in 2025 to USD 4.4 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).
Rising cancer incidence combined with the demand for precision care is the primary driver of the oncology informatics market. This sector unites electronic health records, clinical decision support, genomics, imaging analytics, registry platforms and interoperability tools that consolidate clinical, molecular and outcomes data to inform therapy choices and research. The market matters because it converts complex biomedical signals into actionable insights that can improve survival, streamline trials and optimize spending. Over time the field moved from siloed hospital systems and PACS to cloud-based data lakes, real-world evidence platforms and AI-enabled diagnostics; Flatiron, Tempus and Foundation Medicine exemplify that evolution today.Interoperability and integration of heterogeneous data are the pivotal factors accelerating growth because connecting genomics, imaging, EHR and patient-generated data enables accurate, personalized decision-making and scalable analytics. When data flows seamlessly between systems, clinical decision support can deliver treatment recommendations informed by genomic alterations, as evidenced by molecular tumor boards that combine sequencing from Foundation Medicine with EHR records to select targeted therapies. This capability drives adoption by payers and research sponsors seeking real-world evidence for outcomes-based contracts, which in turn attracts investment in cloud platforms, AI model development and trial-matching services that create clear commercial opportunities worldwide and scalability.
How is AI improving clinical decision support in the oncology informatics market?
AI is improving clinical decision support in oncology by combining multimodal data and predictive models to deliver explainable patient specific treatment guidance and streamline clinician workflows. Key aspects are integration of genomics pathology imaging and electronic records model driven therapy suggestions and automated trial matching that reduce clinician cognitive load. The market is moving from pilots to deployed platforms as vendors embed AI in tumor board workflows and guideline alignment to make recommendations more actionable for care teams. Tempus has expanded multimodal AI in provider workflows. Real world evidence from liquid biopsy platforms is informing regulatory and treatment decisions. Evidence based clinical AI is featured at industry events.Tempus March 2026, announced an expanded collaboration with Merck to train AI models on its de-identified multimodal oncology dataset supporting faster biomarker discovery and smarter trial matching. This development helps oncology informatics grow by feeding real world molecular insights directly into decision support at the point of care.
Market snapshot - (2026-2033)
Global Market Size
USD 4.42 Billion
Largest Segment
Electronic Health Records (EHR) for Oncology
Fastest Growth
Clinical Decision Support Systems (CDSS)
Growth Rate
12.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global oncology informatics market is segmented by software solution type, deployment model, application focus, end-user and region. Based on software solution type, the market is segmented into Electronic Health Records (EHR) for Oncology, Clinical Decision Support Systems (CDSS), Patient Registry & Population Health Management and Radiation & Chemotherapy Information Systems. Based on deployment model, the market is segmented into Cloud-based Oncology Platforms (SaaS) and On-premise/Legacy Hospital Infrastructure. Based on application focus, the market is segmented into Personalized Medicine & Genomics Integration, Clinical Trial Management & Patient Matching, Workflow Automation & Revenue Cycle and Remote Patient Monitoring & PROs. Based on end-user, the market is segmented into Specialized Cancer Centers & Oncology Clinics, Academic Medical Research Institutes and Pharmaceutical & Biotech Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Electronic Health Records (EHR) for Oncology segment dominates because oncology care depends on centralized longitudinal clinical data and tailored workflows that support complex treatment regimens. EHRs consolidate diagnostics, treatment plans, medication regimens, and imaging into a unified clinical hub, enabling multidisciplinary coordination. This consolidation reduces fragmentation, streamlines documentation and billing, and supports interoperability with labs and cancer registries, driving provider preference and sustained investment in oncology-specific EHR capabilities.
However, Clinical Decision Support Systems (CDSS) are witnessing the strongest growth momentum as oncology adopts AI driven treatment pathways and evidence synthesis. CDSS improve diagnostic accuracy, integrate molecular insights, and automate guideline recommendations, accelerating clinician acceptance and expanding demand from hospitals, research institutes, and biotech firms.
Personalized Medicine & Genomics Integration segment leads because oncology increasingly relies on molecularly guided therapeutic choices and complex genomic datasets that require specialized informatics. Integrating sequencing, variant interpretation, and clinical context into platforms enables precise treatment selection, biomarker informed trial enrollment, and targeted drug selection. That capability compels health systems and research centers to invest in analytics, data pipelines, and molecular tumor board workflows, creating persistent demand for interoperable omics-enabled solutions.
Meanwhile, Clinical Trial Management & Patient Matching is the most rapidly expanding area as sponsors and providers prioritize efficient recruitment and decentralized trial models. Advances in patient phenotyping, algorithmic matching to molecular eligibility, and platform based site coordination shorten enrollment timelines and reduce costs, opening new commercial pathways between oncology informatics vendors, clinical research organizations, and pharmaceutical partners.
To get detailed segments analysis, Request a Free Sample Report
North America dominates due to a dense concentration of advanced medical centers, integrated health systems, and a mature digital health ecosystem that supports rapid adoption of oncology informatics solutions. Strong collaboration between academic research institutions, industry vendors, and payer organizations fosters development and early deployment of sophisticated analytics, genomic integration, and clinical decision support. Regulatory and reimbursement environments encourage innovation in personalized oncology care, while established clinical trial networks generate large volumes of high quality data for real world evidence use. The market benefits from a deep pool of specialized talent, established interoperability frameworks, and sustained investment in health IT infrastructure, which together create a reinforcing environment for solution refinement and commercialization.
Oncology Informatics Market in United States is characterized by leadership in precision oncology integration, widespread electronic medical record adoption, and close ties between research centers and commercial vendors. Institutions prioritize analytics that support complex treatment pathways and trial matching, and there is strong demand for solutions that combine clinical, imaging, and genomic data. Commercialization pathways are well established, enabling rapid scale up of proven platforms across academic and community oncology settings.
Oncology Informatics Market in Canada reflects coordinated efforts across provincial cancer agencies to modernize data capture and improve care continuity. Emphasis on interoperable systems and centralized registries supports population level insights and multidisciplinary care coordination. Public procurement models and regional digital health initiatives encourage vendor collaboration and tailored deployments that address rural access and equity, while academic partnerships drive clinical validation and knowledge transfer.
The rapid expansion in Europe is driven by harmonized clinical priorities across national health systems, strategic public investments in health digitization, and a strong life sciences sector that emphasizes real world evidence generation. Pan regional initiatives encourage secure data sharing and cross border research collaborations, while regulatory frameworks stress patient data protection and quality standards that raise demand for compliant informatics solutions. Oncology centers and comprehensive cancer networks are adopting integrated pathways that rely on analytics, decision support, and registry linkage to improve outcomes. A vibrant medtech and digital health vendor community, combined with active translational research in precision medicine, fosters deployment of advanced informatics tools across diverse care settings, accelerating market growth and innovation diffusion.
Oncology Informatics Market in Germany is anchored by robust hospital networks and a strong medtech industry that prioritize interoperability and high quality clinical documentation. Cancer centers and university hospitals seek solutions that integrate diagnostic workflows, imaging, and molecular data to support multidisciplinary decision making. Policy emphasis on digital health modernization and statutory reimbursement frameworks creates an environment favorable to comprehensive platform implementations and collaboration with domestic and international vendors.
Oncology Informatics Market in United Kingdom benefits from centralized health system structures and national data initiatives that enable rapid procurement and scale up of validated solutions. Focus on building cohesive cancer registries and leveraging national data assets drives adoption of analytics and decision support tools to inform pathway improvement. Partnerships between health system bodies, research institutions, and technology firms accelerate proof of concept testing and national rollouts, supporting a dynamic and fast growing landscape.
Oncology Informatics Market in France is evolving around coordinated cancer plans and regional oncology networks that prioritize integrated care pathways. Increasing collaboration between public institutions and private vendors, along with emphasis on data security and patient centric approaches, supports deployment of tailored informatics platforms. Growth is fueled by investments in regional centers of excellence and activities that bridge clinical research with routine care.
Asia Pacific is strengthening its role through focused investments in hospital modernization, digital health strategies, and public private partnerships that foster local innovation and international collaboration. Growing capabilities in artificial intelligence and genomics are being integrated into clinical workflows, while strong IT infrastructure in key markets supports rapid deployment of cloud enabled and interoperable systems. Regional governments and health systems are piloting data driven oncology initiatives to improve patient access and pathway efficiency, and local vendor ecosystems are maturing to offer tailored solutions. Cross border collaborations with global research networks and increased emphasis on clinical validation are accelerating adoption and enhancing regional competitiveness.
Oncology Informatics Market in Japan is shaped by advanced hospital IT environments and strong integration between research institutions and clinical practice. There is a clear focus on harmonizing electronic records with molecular and imaging data to support precision medicine, and vendor activity emphasizes compliance with stringent regulatory standards. Collaborative efforts between academic centers and industry promote validated solutions that address complex care coordination and aging population needs.
Oncology Informatics Market in South Korea leverages high quality digital infrastructure and a vibrant technology sector to drive rapid uptake of AI enabled analytics and integrated care platforms. Hospitals and research organizations collaborate closely with domestic vendors to develop solutions tailored to local clinical workflows, while government initiatives and biotech clusters support clinical research integration and scalable implementations across urban and regional care settings.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Integration With Electronic Health Records
Advances In Artificial Intelligence
High Implementation And Integration Costs
Data Privacy And Regulatory Complexity
Request Free Customization of this report to help us to meet your business objectives.
Competition in the oncology informatics market is intensifying as incumbents use acquisitions and platform partnerships to secure multimodal clinical and molecular datasets while specialist vendors push AI product innovation to differentiate. Recent examples include a major oncology vendor acquisition that consolidated therapy and software portfolios and a multiparty partnership to build a large oncology foundation model, driving rivals to pursue data licensing, cloud integrations, and clinical partnerships to defend market share.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global oncology informatics market is propelled primarily by rising cancer incidence and demand for precision care, with advances in artificial intelligence further accelerating adoption through multimodal decision support and trial matching. Integration with EHRs and cloud platforms creates commercial opportunities, yet high implementation and integration costs remain a significant restraint that can slow uptake among smaller providers. North America dominates the market thanks to advanced clinical infrastructure, dense research networks and mature digital health ecosystems. Electronic Health Records for Oncology remains the dominant segment as providers prioritize centralized longitudinal data and tailored oncology workflows to support multidisciplinary care and outcome-driven strategies.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 4.42 Billion |
| Market size value in 2033 | USD 4.4 Billion |
| Growth Rate | 12.8% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Oncology Informatics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Oncology Informatics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Oncology Informatics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Oncology Informatics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
